A U.S. appeals court has sided with health care giant Johnson & Johnson – throwing out an earlier $482 million verdict in a patent infringement case, according to a story in the Newark Star Ledger.
A doctor had claimed Johnson & Johnson infringed on the patent for his invention, which used a permeable barrier to treat injured tissue. He claimed the company improperly used the technology for a type of stent ...
continue reading...
A Los Angeles jury recently awarded $8.3 million in damages to a man who claimed he suffered metal poisoning from an artificial hip implant manufactured by Johnson & Johnson’s DePuy Orthopaedics division. That was the first of about 10,000 lawsuits over the hip implant to go to trial.
A woman who received a faulty hip implant that had to be replaced after only three years should get at least $5 million from the company that manufactured it, her lawyer told a Chicago jury.
A study published in the British Medical Journal concluded that a high concentration of the metal cobalt in a patient’s blood is a “significant risk factor” for failure of an all-metal artificial hip joint, Medscape Today News reports.
An opinion piece in USA Today contrasts health care giant Johnson & Johnson’s actions in 1982, when seven people died after taking Tylenol spiked with cyanide; and in the late 2000’s when concerns started to emerge about the company’s all-metal hip implants.
A story in the San Francisco Chronicle describes the DePuy Orthopaedics articular surface replacement hip implant as one of the largest medical device failures in history.